Lead Compound Analysis Is Making Inroads At USPTO
The lead compound analysis, or LCA, originally a creature of abbreviated new drug application litigation, has more recently found its way into chemical obviousness arguments at the U.S. Patent and Trademark...To view the full article, register now.
Already a subscriber? Click here to view full article